SCHEMBL17048623

SCHEMBL17048623

FC(F)(F)c1cc(CN2CCCC2)cc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)c1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.59
KDM4E B2RXH2 2/20 0.59
GAA P10253 1/20 0.59
CASP1 P29466 1/20 0.56
CASP5 P51878 1/20 0.56
CYP2D6 P10635 7/20 0.54
CYP3A4 P08684 6/20 0.54
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
TP53 P04637 1/20 0.52
CYP2C19 P33261 3/20 0.49
USP2 O75604 3/20 0.49
CYP1A2 P05177 2/20 0.49
TSHR P16473 5/20 0.48
CYP2C9 P11712 2/20 0.47
CNR2 P34972 1/20 0.46
CHKA P35790 1/20 0.46
HPGD P15428 1/20 0.45
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6028265 0.93 ALDH1A1 (0.67) ALDH1A1KDM4EGAACASP1CASP5
SCHEMBL31010361 0.91 ALDH1A1 (0.70) ALDH1A1KDM4EGAACASP1CASP5
SCHEMBL8974017 0.87 ALDH1A1 (0.60) ALDH1A1KDM4EGAACASP1CASP5
SCHEMBL545692 0.81 ALDH1A1 (0.58) ALDH1A1KDM4EGAACASP1CASP5
SCHEMBL29967920 0.81 ALDH1A1 (0.58) ALDH1A1KDM4EGAACASP1CASP5
SCHEMBL10104420 0.81 ALDH1A1 (0.58) ALDH1A1KDM4EGAACASP1CASP5
SCHEMBL545978 0.80 ALDH1A1 (0.60) ALDH1A1KDM4EGAACASP1CASP5
Hydrochloric Acid SCHEMBL30349712 0.80 ALDH1A1 (0.56) ALDH1A1KDM4EGAACASP1CASP5
SCHEMBL13960087 0.80 ALDH1A1 (0.60) ALDH1A1KDM4EGAACASP1CASP5
SCHEMBL7812427 0.79 CHKA (0.68) ALDH1A1KDM4EGAACASP1CASP5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015130957-A1 HETEROCYCLIC INHIBITORS OF THE SODIUM CHANNEL Zalicus Pharmaceuticals, Ltd. (US) 2015-09-03 WO disclosed